Breast CancerФаза 2NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Zanidatamab
54 Phase 2 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Breast54 studies
Breast CancerФаза 2NCT06695845
Zanidatamab
Breast CancerФаза 2NCT07694986
cDC1 Vaccine, Trastuzumab, Nivolumab
Breast CancerФаза 2NCT06444269
Radiomics on MRI, microbubble CEUS Contrast Enhanced Ultrasound (CEUS)
Metastatic HER2-Negative Breast CarcinomaФаза 2NCT05770531
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Sacituzumab Govitecan
Anatomic Stage I Breast Cancer AJCC v8Фаза 2NCT07158021
Biospecimen Collection, Electronic Health Record Review, Goserelin, Leuprolide
Breast CancerФаза 2NCT03936478
MRIdian Radiation Treatment Unit